Viewing Study NCT03069534


Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2026-07-07 @ 1:12 AM
Study NCT ID: NCT03069534
Status: UNKNOWN
Last Update Posted: 2017-03-03
First Post: 2017-02-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Adjunctive Recombinant Human Interleukin-2 Therapy in Patients With MDR-TB
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None MDR TB View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MDR-TB View
None rhIL-2 View
None immunotherapy View